02666 UNI MEDICAL
- 4.900
- +0.140+2.94%
UNI MEDICAL News
Hong Kong Stock Concept Tracking | Favorable Policies Drive Continued Demand Expansion, Domestic Medical Device Companies Usher in Development Opportunities (with concept stocks)
Guodu Securities believes that overall, as the medical sector implements equipment renewal actions, it will drive the release of domestic demand for medical equipment.
CITIC Capital Holdings Limited sold 1.6405 million shares of Global Healthcare (02666.HK) common shares worth approximately HK$7.6786 million
On May 3, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on May 3, CITIC Capital Holdings Limited sold $1,640,500 common shares of $Global Healthcare (02666.HK) at an average price of HK$4.7355 per share on April 29, worth approximately HK$7.7686 million. After the sale, CITIC Capital Holdings Limited's latest shareholding was 226 million shares, and the good position ratio fell from 12.34% to 11.93%. Photo source: Stock Exchange Stock Exchange
環球醫療：本集團未經審核二零二四年第一季度營運概要
環球醫療：年度報告2023
Global Healthcare (02666.HK) completed the issuance of 500 million yuan of renewable corporate bonds
On April 22, GLONGHUI (02666.HK) announced that China Global Leasing Co., Ltd. (the “Issuer”), a wholly-owned subsidiary of the company, will issue the first renewable corporate bonds in 2024 in China. The issuance of the current corporate bonds was completed in China on April 22, 2024. The total principal amount of the current corporate bonds issued is RMB 500 million. The base period is 3 years from April 22, 2024, and the fixed interest rate is 2.99%. At the end of the agreed base period and at the end of each renewal cycle, the issuer has the right to exercise the right to renew. The issue price is RMB per bond
Global Healthcare (02666.HK) subsidiary plans to issue renewable corporate bonds of no more than 500 million yuan
Global Healthcare (02666.HK) announced that China Global Leasing Co., Ltd. (issuer), a wholly-owned subsidiary of the company, has received approval from the China Securities Regulatory Commission (CSRC) to publicly issue domestic renewable corporate bonds with a total principal amount of up to RMB 2 billion to qualified investors in China. The remaining amount as of the date of this announcement is RMB 2 billion. The bonds were issued in instalments, and the total principal amount issued this time was no more than RMB 500 million (including RMB 500 million).
Professional and industrial net profit surged 271.8%, and Global Healthcare (2666.HK) can be expected to grow rapidly
As the overall development strategy continues to be implemented, supported by multiple advantages such as stable fundamentals and sufficient funding, it is worth looking forward to the explosive growth of global healthcare in the future.
China Post Securities: Endogenous growth is steady, and the Hong Kong stock healthcare services sector's valuation is highly attractive
Judging from the overall performance of medical service targets in Hong Kong stocks, with the exception of ICL's high revenue base in the early COVID-19 period, where dental revenue was affected by dental implant collection, most of the revenue from other medical service targets increased relatively well.
Global Healthcare (02666.HK) 2023 Annual Report Review: Health-Driven Performance Financing Structure Improvements
Incident: Global Healthcare released its 2023 annual report. The company's operating revenue/net profit to mother during the reporting period was RMB 136.50/2.021 billion, +13.1%/+7.0% YoY; ROE was 13.63%, YoY
Genertec Universal Medical Group Clocks 7% Rise in 2023 Profit
Genertec Universal Medical Group's (HKG:2666) attributable net profit rose 7% in 2023 to 2.02 billion yuan from 1.89 billion yuan in 2022, according to a Hong Kong bourse filing on Wednesday. Earnings
Global Healthcare (2666.HK) announced its 2023 annual results, and the net profit of the healthcare business increased by 45.8%
In 2023, Global Healthcare will continue to be deeply involved in the healthcare sector, forge ahead, overcome difficulties, and continue to repay society and shareholders with steady growth performance: achieved total revenue of RMB 13.650 billion for the whole year, an increase of 13.1% over the same period of the previous year. Among them, the healthcare business achieved revenue of RMB 7.833 billion, an increase of 22.9% over the same period of the previous year, and its share of total revenue has increased to 57.4%; Net profit of RMB 2,199 billion, an increase of 5.4% over the same period last year, of which the healthcare business contributed RMB 5.4% over the same period last year 454 million yuan, an increase over the same period last year
Global Healthcare (02666) Announces 2023 Annual Results Profit attributable to shareholders of 2,021 billion yuan, an increase of 7% year-on-year
Global Healthcare (02666) announced its annual results for the year ended December 31, 2023. The group achieved revenue of $13.65 billion (RMB, same below) during the period, an increase of 13.1%; profit attributable to shareholders of $2,021 billion, an increase of 7% over the previous year; basic income per share of $1.07; and proposed to pay a final dividend of HK$0.35 per share.
UNI MEDICAL: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Genertec Universal Medical Unit Raises 500 Million Yuan From Bond Issue
Genertec Universal Medical Group (HKG:2666) unit China Universal Leasing has completed the issue of 500 million yuan of corporate bonds in China, a Tuesday filing on the Hong Kong bourse stated. The b
Global Healthcare (02666.HK) completed issuing 500 million yuan of corporate bonds in China
On March 25, Global Healthcare (02666.HK) announced that China Global Leasing Co., Ltd. (the “issuer”), a wholly-owned subsidiary of the company concerned, will publicly issue the third installment of the 2024 corporate bonds in China. The issuance of this corporate bond was completed in China on March 25, 2024. The total principal amount of the final issuance of this issue of corporate bonds was RMB 500 million. The basic period is five years from March 25, 2024 (with issuer redemption options, adjustment of coupon interest rate options, and investors' resale options at the end of the 3rd year and the end of the 4th year), with a fixed interest rate of 2.85%. The release price is per person
Genertec Universal Medical Arm to Sell Bonds Worth 1 Billion Yuan
Genertec Universal Medical Group (HKG:2666) subsidiary China Universal Leasing will sell domestic bonds worth 1 billion yuan, according to a Wednesday filing with the Hong Kong bourse. The five-year b
Hong Kong Stock Concept Tracking | Policies Promote Large-scale Equipment Renewal Agencies to Pay Attention to Medical Equipment Procurement Needs (with concept stocks)
On March 1, the Executive Meeting of the State Council reviewed and approved the “Action Plan to Promote Large-scale Equipment Renewal and Trade-in of Consumer Goods”, which proposed “promoting the orderly upgrading of equipment, transportation equipment, and old agricultural machinery, education and medical equipment in key industries.” The equipment update focuses on the field of “building diplomatic relations between workers and agriculture, education, culture and medicine”. The investment scale was about 6 trillion yuan in '27, with an additional investment of about 300 billion dollars every year, focusing on key industries such as metals, chemicals, building materials, electricity, machinery, transportation, textiles, and electronics. Financial support includes subsidies, tax incentives, and reloan interest rates. According to “Chinese Medical Devices
Global Healthcare (02666.HK) held a board meeting on March 27 to consider and approve the annual results
Glonghui, March 11 | Global Healthcare (02666.HK) announced that it is planning to hold a board meeting on March 27, 2024 (Wednesday) to consider and approve (among other things) the Group's annual results for the year ended 31 December 2023, and the proposed final dividend (if any).
UNI MEDICAL: DATE OF BOARD MEETING
Genertec Universal Unit Issues 1 Billion Yuan Bonds in China
Genertec Universal Medical Group (HKG:2666) unit China Universal Leasing has completed the issue of 1 billion yuan worth of bonds in China. The debt securities have an interest rate of 2.65% per annum
Analysis
Price Target
No Data
